pravastatin has been researched along with Heart Valve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daitoku, K; Fukuda, I; Hanada, H; Higuma, T; Okumura, K; Osanai, T; Saito, S; Yokoyama, H | 1 |
| Cheng, G; Elmariah, S; Kaplan, FS; Mohler, ER; Wu, B | 1 |
1 trial(s) available for pravastatin and Heart Valve Diseases
| Article | Year |
|---|---|
Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.
Topics: Adiponectin; Aged; Cholesterol, LDL; Coronary Artery Disease; Female; Fluorobenzenes; Heart Valve Diseases; Humans; Interleukin-6; Intra-Abdominal Fat; Male; Middle Aged; Oxidative Stress; Pravastatin; Protein Carbonylation; Pyrimidines; Rosuvastatin Calcium; Subcutaneous Fat; Sulfonamides; Tumor Necrosis Factor-alpha | 2011 |
1 other study(ies) available for pravastatin and Heart Valve Diseases
| Article | Year |
|---|---|
Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
Topics: Animals; Aortic Valve; Calcinosis; Cell Differentiation; Cells, Cultured; Cholesterol; Fibroblasts; Heart Valve Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Osteoblasts; Pravastatin; Protein Prenylation; Simvastatin; Stromal Cells; Swine | 2005 |